Answers are grounded in this paper and cite their sources.
A novel pathway for ex vivo maytansinoid release from thioether linked antibody maytansinoid conjugates (AMCs) upon incubation in human plasma has been identified. A thioether succinimide-linked AMC can undergo chemical oxidation followed by sulfoxide elimination under mild aqueous conditions (pH 5.5-7.5, 37 °C). Oxidized thioether-linked AMCs exhibit high, target-specific cytotoxicity toward cancer cells.
No takes yet. Share an insight, caveat, or question.
Fishkin et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: